These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 12124337)

  • 1. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
    Lupold SE; Hicke BJ; Lin Y; Coffey DS
    Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.
    Lupold SE
    Am J Clin Exp Urol; 2018; 6(2):78-86. PubMed ID: 29666835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.
    Smith-Jones PM; Vallabahajosula S; Goldsmith SJ; Navarro V; Hunter CJ; Bastidas D; Bander NH
    Cancer Res; 2000 Sep; 60(18):5237-43. PubMed ID: 11016653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer.
    Bandekar A; Zhu C; Jindal R; Bruchertseifer F; Morgenstern A; Sofou S
    J Nucl Med; 2014 Jan; 55(1):107-14. PubMed ID: 24337602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity.
    Anilkumar G; Rajasekaran SA; Wang S; Hankinson O; Bander NH; Rajasekaran AK
    Cancer Res; 2003 May; 63(10):2645-8. PubMed ID: 12750292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of monoclonal antibodies specific for protein conformational epitopes present in prostate-specific membrane antigen (PSMA).
    Tino WT; Huber MJ; Lake TP; Greene TG; Murphy GP; Holmes EH
    Hybridoma; 2000 Jun; 19(3):249-57. PubMed ID: 10952413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
    Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
    Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer.
    Ptacek J; Zhang D; Qiu L; Kruspe S; Motlova L; Kolenko P; Novakova Z; Shubham S; Havlinova B; Baranova P; Chen SJ; Zou X; Giangrande P; Barinka C
    Nucleic Acids Res; 2020 Nov; 48(19):11130-11145. PubMed ID: 32525981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).
    Luthi-Carter R; Barczak AK; Speno H; Coyle JT
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1020-5. PubMed ID: 9694964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
    Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
    Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.
    Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S
    Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous electrochemical detection of both PSMA (+) and PSMA (-) prostate cancer cells using an RNA/peptide dual-aptamer probe.
    Min K; Song KM; Cho M; Chun YS; Shim YB; Ku JK; Ban C
    Chem Commun (Camb); 2010 Aug; 46(30):5566-8. PubMed ID: 20407731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSMA specific single chain antibody-mediated targeted knockdown of Notch1 inhibits human prostate cancer cell proliferation and tumor growth.
    Su Y; Yu L; Liu N; Guo Z; Wang G; Zheng J; Wei M; Wang H; Yang AG; Qin W; Wen W
    Cancer Lett; 2013 Sep; 338(2):282-91. PubMed ID: 23752065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.
    Bacich DJ; Pinto JT; Tong WP; Heston WD
    Mamm Genome; 2001 Feb; 12(2):117-23. PubMed ID: 11210180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate targeting ligands based on N-acetylated alpha-linked acidic dipeptidase.
    Tang H; Brown M; Ye Y; Huang G; Zhang Y; Wang Y; Zhai H; Chen X; Shen TY; Tenniswood M
    Biochem Biophys Res Commun; 2003 Jul; 307(1):8-14. PubMed ID: 12849974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carbohydrate moieties on the folate hydrolysis activity of the prostate specific membrane antigen.
    Ghosh A; Heston WD
    Prostate; 2003 Oct; 57(2):140-51. PubMed ID: 12949938
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.